IPSEN SA S/ADR (IPSEY) earnings
Quarterly and annual IPSEY reports and results, each read against the price at its own news timestamp. Back to the IPSEY overview →
1 measured IPSEY earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance | Press release | +0.00% | -0.44% |
Keep exploring
More IPSEY: analyst actions → · SEC filings → · IPSEY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | 296 | -0.65% | 35% |
| Processa Pharmaceuticals, Inc. (PCSA) | 296 | 0.00% | 50% |
| Adicet Bio, Inc. (ACET) | 293 | -0.83% | 36% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 293 | +0.08% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.